Kenvue

KVUE NYSE IPO2023

about KVUE

Kenvue is a leading global specialty chemicals and materials company that develops innovative solutions for industries including healthcare, consumer products, and industrial applications, focusing on sustainable and high-performing products.

type open high low market
cap
volume
stock $20.51 $20.69 $17.14 $39.42B 135.44M
eps price to
earnings
price to
sales
operating
margin
profit
margin
yield
+$0.22 30.11 9.38 18.03% 10.94% 4.45%
Looks like old Bobby Jr. is finally doing something useful with that HHS job. Just announced he's gonna drop a report linking taking Tylenol during pregnancy to autism, and of course the media is getting themselves into a frenzy. Stock is taking a nosedive and all the self-described experts are scrambling to say the report is nothing but speculation. Funny how fast the science goes out the window when the dollar signs start disappearing... 💸
Give a thumbs-up reaction to this forum post by weedjoke420 Give a positive rocketship reaction to this forum post by weedjoke420 Give a spicy clown-face reaction to this forum post by weedjoke420 1 reply share report